Drug Information

General Information
Drug ID
DR00292
Drug Name
Procainamide
Synonyms
2-Diethylaminoethylamid kyseliny p-aminobenzoove; 2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]; 4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate; 4-Amino-N-(2-(diethylamino)ethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide; 4-amino-N-(2-diethylaminoethyl)-benzamide; 4-amino-N-(2-diethylaminoethyl)benzamide; Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI); Biocoryl; Novocainamid; Novocainamide; Novocaine amide; Novocamid; P-Amino-N-(2-diethylaminoethyl)benzamide; P-Aminobenzoic diethylaminoethylamide; Procainamida; Procainamida [INN-Spanish]; Procainamide (INN); Procainamide [INN:BAN]; Procainamidum; Procainamidum [INN-Latin]; Procaine amide; Procamide; Procan; Procan (TN); Procanbid; Procanbid (TN); Procapan; Procapan (free base); Pronestyl; Pronestyl (TN); Pronestyl-Sr
Drug Type
Small molecular drug
Indication Ventricular arrhythmias [ICD11: BC71] Approved [1]
Therapeutic Class
Antiarrhythmic Agents
Structure
3D MOL 2D MOL
Formula
C13H21N3O
Canonical SMILES
CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
InChI
InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)
InChIKey
REQCZEXYDRLIBE-UHFFFAOYSA-N
CAS Number
CAS 51-06-9
Pharmaceutical Properties Molecular Weight 235.33 Topological Polar Surface Area 58.4
Heavy Atom Count 17 Rotatable Bond Count 6
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
XLogP
0.9
PubChem CID
4913
PubChem SID
10524666 , 11111690 , 11111691 , 11120271 , 11120759 , 11121247 , 11121528 , 11122008 , 11132695 , 11336106 , 11361345 , 11362597 , 11363730 , 11365159 , 11366292 , 11367721 , 11368854 , 11370465 , 11370466 , 11371829 , 11373322 , 11374112 , 11375883 , 11377016 , 11382660 , 11462317 , 11466365 , 11467485 , 11485065 , 11486030 , 11489111 , 11490371 , 11492302 , 11494650 , 15220788 , 26751611 , 26751612 , 29223991 , 3138733 , 3296200 , 46507313 , 47216907 , 47440400 , 47662439 , 47810893 , 5227620 , 7980387 , 8153024 , 87927 , 9605
ChEBI ID
ChEBI:8428
TTD Drug ID
D0U5SI
DT(s) Transporting This Drug MATE1 Transporter Info Multidrug and toxin extrusion protein 1 Substrate [2]
MATE2 Transporter Info Multidrug and toxin extrusion protein 2 Substrate [2]
OCT-1 Transporter Info Organic cation transporter 1 Substrate [3]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MATE1 Transporter Info Km = 1230 microM Human embryonic kidney cells (HEK293)-MATE1 [2]
MATE2 Transporter Info Km = 1580 microM Human embryonic kidney cells (HEK293)-MATE2K [2]
MATE2 Transporter Info Km = 4100 microM Human embryonic kidney cells (HEK293)-MATE2K [4]
References
1 Procainamide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71.
3 Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42.
4 Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol. 2006 Aug;17(8):2127-35.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.